Post‐translational modification by O‐GlcNAc: Another way to change protein function

Modification of intracellular proteins by the β‐linkage of the monosaccharide, N‐acetylglucosamine to serine or threonine hydroxyls (O‐GlcNAc) is abundant and reversible. Although many proteins bear this post‐translational covalent modification, the changes in function of the proteins as a result of this modification are only starting to be understood. In this article, we describe how aspects of the flux from the glucose backbone to this modification are modified and how the cellular activity and content of the GC‐box binding transcription factor, Sp1, is altered by O‐glycosylation. The association of the enzyme that puts on the O‐GlcNAc modification with the bi‐functional enzyme that removes this modification is discussed relative to the transition between transcriptional repression and activation. J. Cell. Biochem. 98: 1062–1075, 2006. © 2006 Wiley‐Liss, Inc.

[1]  G. Hart,et al.  Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. , 1994, The Journal of biological chemistry.

[2]  E. Meese,et al.  Novel immunogenic antigen homologous to hyaluronidase in meningioma. , 1998, Human molecular genetics.

[3]  N. Olszewski,et al.  SECRET AGENT and SPINDLY have overlapping roles in the development of Arabidopsis thaliana L. Heyn. , 2006, Journal of experimental botany.

[4]  J. E. Kudlow,et al.  The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. , 2001, The Biochemical journal.

[5]  Xiaoyong Yang,et al.  An N-terminal Region of Sp1 Targets Its Proteasome-dependent Degradation in Vitro* , 1999, The Journal of Biological Chemistry.

[6]  G. Hart,et al.  Glycosylation of the murine estrogen receptor-alpha. , 2000, The Journal of steroid biochemistry and molecular biology.

[7]  R. Tjian,et al.  Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators , 1993, Cell.

[8]  J. E. Kudlow,et al.  Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets. , 2000, Biochemical and biophysical research communications.

[9]  R. Kornfeld Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine. , 1967, The Journal of biological chemistry.

[10]  G. Hart,et al.  O-GlcNAc: a regulatory post-translational modification. , 2003, Biochemical and biophysical research communications.

[11]  G. Hart,et al.  Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. , 2001, Analytical biochemistry.

[12]  G. Hart,et al.  Perturbations in O-linked β-N-Acetylglucosamine Protein Modification Cause Severe Defects in Mitotic Progression and Cytokinesis* , 2005, Journal of Biological Chemistry.

[13]  A. Paterson,et al.  Location and characterization of the O-GlcNAcase active site. , 2006, Biochimica et biophysica acta.

[14]  G. Hart,et al.  Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress , 2004, Journal of Biological Chemistry.

[15]  A. Paterson,et al.  Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. , 2000, The Biochemical journal.

[16]  Eric C. Griffith,et al.  The Many Forks in FOXO's Road , 2003, Science's STKE.

[17]  G. Hart,et al.  Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. , 1997, Annual review of biochemistry.

[18]  E. Meese,et al.  Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. , 2001, Biochemical and biophysical research communications.

[19]  G. Hart,et al.  O-Glycosylation of Nuclear and Cytosolic Proteins , 2000, The Journal of Biological Chemistry.

[20]  O. Sezer,et al.  Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion , 2003, Journal of Cancer Research and Clinical Oncology.

[21]  J. Wyss,et al.  Accumulation of protein O‐GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O‐GlcNAc metabolism , 2004, Journal of neurochemistry.

[22]  Xiaoyong Yang,et al.  O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Paterson,et al.  Transforming growth factor alpha in arterioles: cell surface processing of its precursor by elastases , 1990, Molecular and cellular biology.

[24]  G. Hart,et al.  Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. , 2001, Biochemistry.

[25]  A. Paterson,et al.  Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Kim Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death. , 2001, Biochemical and biophysical research communications.

[27]  A. Paterson,et al.  Characterization of the Histone Acetyltransferase (HAT) Domain of a Bifunctional Protein with Activable O-GlcNAcase and HAT Activities*♦ , 2004, Journal of Biological Chemistry.

[28]  G. Hart,et al.  Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. , 2002, Current opinion in chemical biology.

[29]  Xiaoyong Yang,et al.  O-GlcNAc Modification Is an Endogenous Inhibitor of the Proteasome , 2003, Cell.

[30]  S. Milligan,et al.  Inhibition of NF-kappa B with proteasome inhibitors enhances apoptosis in human lung adenocarcinoma cells in vitro. , 2001, Anticancer research.

[31]  T. Shin,et al.  5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression , 1992, Molecular and cellular biology.

[32]  J. Kuromitsu,et al.  cDNA cloning and mapping of a novel subtype of glutamine:fructose-6-phosphate amidotransferase (GFAT2) in human and mouse. , 1999, Genomics.

[33]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.

[34]  G. Hart,et al.  Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.

[35]  D. Coppola,et al.  CEP1612, a dipeptidyl proteasome inhibitor, induces p21WAF1 and p27KIP1 expression and apoptosis and inhibits the growth of the human lung adenocarcinoma A-549 in nude mice. , 2001, Cancer research.

[36]  M. Hengartner Apoptosis Corralling the Corpses , 2001, Cell.

[37]  R. Haltiwanger,et al.  Mitotic Arrest with Nocodazole Induces Selective Changes in the Level of O-Linked N-Acetylglucosamine and Accumulation of Incompletely Processed N-Glycans on Proteins from HT29 Cells* , 1997, The Journal of Biological Chemistry.

[38]  F. Chen,et al.  Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[39]  S. Safe,et al.  Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. , 2003, Endocrinology.

[40]  P. O'Hara,et al.  Molecular cloning, cDNA sequence, and bacterial expression of human glutamine:fructose-6-phosphate amidotransferase. , 1992, The Journal of biological chemistry.

[41]  J. E. Kudlow,et al.  O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions , 1997, Molecular and cellular biology.

[42]  D. Barford,et al.  The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR‐mediated protein–protein interactions , 1998, The EMBO journal.

[43]  I. Han,et al.  Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility , 1997, Molecular and cellular biology.

[44]  G. Hart,et al.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  N. Greenspan,et al.  Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Paterson,et al.  Glucose stimulates protein modification by O-linked GlcNAc in pancreatic β cells: Linkage of O-linked GlcNAc to β cell death , 2000 .

[47]  L. Freedman Increasing the Complexity of Coactivation in Nuclear Receptor Signaling , 1999, Cell.

[48]  A. Paterson,et al.  Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Barzilai,et al.  A nutrient-sensing pathway regulates leptin gene expression in muscle and fat , 1998, Nature.

[50]  J. Hanover,et al.  O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.

[51]  Gerald W. Hart,et al.  Glycosylation of Nucleocytoplasmic Proteins: Signal Transduction and O-GlcNAc , 2001, Science.

[52]  J. E. Kudlow,et al.  Purification of the O-glycosylated protein p135 and identification as O-GlcNAc transferase. , 2001, Biochemical and biophysical research communications.

[53]  A. Paterson,et al.  Role of glucosamine synthesis in the stimulation of TGF-alpha gene transcription by glucose and EGF. , 1996, The American journal of physiology.

[54]  D. Wang,et al.  Cloning and partial characterization of the mouse glutamine:fructose-6-phosphate amidotransferase (GFAT) gene promoter. , 1997, Nucleic acids research.

[55]  Xiaoyong Yang,et al.  Phosphorylation of Human Glutamine:Fructose-6-phosphate Amidotransferase by cAMP-dependent Protein Kinase at Serine 205 Blocks the Enzyme Activity* , 2000, The Journal of Biological Chemistry.

[56]  R. Duggirala,et al.  A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. , 2005, Diabetes.

[57]  R. Tjian,et al.  Distinct regions of Sp1 modulate DNA binding and transcriptional activation. , 1988, Science.

[58]  G. Hart,et al.  Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  W. G. Kelly,et al.  RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. , 1993, The Journal of biological chemistry.

[60]  A. Paterson,et al.  Regulation of glutamine:fructose-6-phosphate amidotransferase gene transcription by epidermal growth factor and glucose. , 1995, Endocrinology.

[61]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[62]  I. G. Fantus,et al.  Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[63]  G. Hart,et al.  Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. , 2005, Endocrinology.

[64]  J. Hanover,et al.  Mutational Analysis of the Catalytic Domain of O-Linked N-Acetylglucosaminyl Transferase* , 2005, Journal of Biological Chemistry.

[65]  Q. Dou,et al.  Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[66]  V. Hascall,et al.  Proteoglycan core protein families. , 1986, Annual review of biochemistry.

[67]  G. Hart,et al.  Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[68]  U. Sauer,et al.  High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. , 1998, The Journal of clinical investigation.

[69]  B. V. Van Tine,et al.  Assignment of N-acetyl-D-glucosaminidase (Mgea5) to rat chromosome 1q5 by tyramide fluorescence in situ hybridization (T-FISH): synteny between rat, mouse and human with Insulin Degradation Enzyme (IDE) , 2004, Cytogenetic and Genome Research.

[70]  C. Glass,et al.  The histone deacetylase-3 complex contains nuclear receptor corepressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Jinek,et al.  The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.

[72]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[73]  G. Hart,et al.  c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (*) , 1995, The Journal of Biological Chemistry.

[74]  A. Paterson,et al.  The Histone Acetyltransferase NCOAT Contains a Zinc Finger-like Motif Involved in Substrate Recognition* , 2006, Journal of Biological Chemistry.

[75]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[76]  L. Gerace,et al.  Monoclonal antibodies identify a group of nuclear pore complex glycoproteins , 1987, The Journal of cell biology.

[77]  Y Li,et al.  [Mitochondria and apoptosis]. , 2000, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[78]  J. E. Kudlow,et al.  Glucose Metabolism to Glucosamine Is Necessary for Glucose Stimulation of Transforming Growth Factor-α Gene Transcription* , 1996, The Journal of Biological Chemistry.

[79]  C. Newgard,et al.  STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing Cells , 1994, Diabetes.

[80]  P. Elliott,et al.  Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. , 2001, Cancer research.

[81]  C. Glass,et al.  Eya protein phosphatase activity regulates Six1–Dach–Eya transcriptional effects in mammalian organogenesis , 2003, Nature.

[82]  G. Parker,et al.  Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[83]  K L Williams,et al.  An in vivo approach for the identification of acceptor sites for O-glycosyltransferases: motifs for the addition of O-GlcNAc in Dictyostelium discoideum. , 1997, Biochemistry.

[84]  R. Tjian,et al.  O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation , 1988, Cell.

[85]  G. Hart,et al.  O-GlcNAc and the control of gene expression. , 1999, Biochimica et biophysica acta.

[86]  R. Tjian,et al.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. , 1991, Genes & development.

[87]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[88]  James O. Wrabl,et al.  Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. , 2001, Journal of molecular biology.

[89]  M. Hengartner,et al.  Death and more: DNA damage response pathways in the nematode C. elegans , 2004, Cell Death and Differentiation.

[90]  G. Hart,et al.  O‐GlcNAc turns twenty: functional implications for post‐translational modification of nuclear and cytosolic proteins with a sugar , 2003, FEBS letters.

[91]  A. Paterson,et al.  Streptozotocin inhibits O-GlcNAcase via the production of a transition state analog. , 2006, Biochemical and biophysical research communications.

[92]  A. Paterson,et al.  Phosphorylation of Mouse Glutamine-Fructose-6-phosphate Amidotransferase 2 (GFAT2) by cAMP-dependent Protein Kinase Increases the Enzyme Activity* , 2004, Journal of Biological Chemistry.

[93]  A. Paterson,et al.  Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion , 2002, Molecular and Cellular Endocrinology.

[94]  Marcel Garcia,et al.  Biological and Clinical Significance of Cathepsin D in Breast Cancer Metastasis , 1996, Stem cells.

[95]  M. Robertson,et al.  Identification of a Negative Regulator of Gibberellin Action, HvSPY, in Barley , 1998, Plant Cell.

[96]  Xiaoyong Yang,et al.  Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins. , 1998, Proceedings of the Association of American Physicians.

[97]  V. Rotter,et al.  Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability To Stabilize p53 , 2001, Molecular and Cellular Biology.

[98]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[99]  W. G. Kelly,et al.  Localization of O-GlcNAc modification on the serum response transcription factor. , 1992, The Journal of biological chemistry.

[100]  C. Glass,et al.  A Corepressor/Coactivator Exchange Complex Required for Transcriptional Activation by Nuclear Receptors and Other Regulated Transcription Factors , 2004, Cell.

[101]  G. Hart,et al.  Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. , 2001, The Journal of biological chemistry.

[102]  Xiaoyong Yang,et al.  Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A Coupling Protein O-GlcNAcylation to Transcriptional Repression , 2002, Cell.

[103]  N. J. Patton,et al.  Mechanisms of nitrosourea-induced beta-cell damage. Alterations in DNA. , 1986, Diabetes.

[104]  N. J. Patton,et al.  Mechanisms of Nitrosourea-Induced β-Cell Damage: Alterations in DNA , 1986, Diabetes.

[105]  J. Hanover,et al.  Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro. , 1990, The Journal of biological chemistry.

[106]  G. Hart,et al.  Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. , 1984, The Journal of biological chemistry.

[107]  M. Mcdaniel,et al.  Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. , 1993, Biochemical and biophysical research communications.

[108]  G. Hart,et al.  Glycosylation of the murine estrogen receptor-α , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[109]  G. Hart,et al.  Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability , 2004, Molecular and Cellular Biology.

[110]  S. Snyder,et al.  Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[111]  J. Direnzo,et al.  p300 is a component of an estrogen receptor coactivator complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[112]  Xiaoyong Yang,et al.  Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. , 2006, Glycobiology.

[113]  P. Shaw,et al.  Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus. , 1996, Oncogene.